These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9562973)
1. Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells. Marambaud P; Ancolio K; Lopez-Perez E; Checler F Mol Med; 1998 Mar; 4(3):147-57. PubMed ID: 9562973 [TBL] [Abstract][Full Text] [Related]
2. C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome. da Costa CA; Ancolio K; Checler F Mol Med; 1999 Mar; 5(3):160-8. PubMed ID: 10404513 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome. Marambaud P; Alves da Costa C; Ancolio K; Checler F Biochem Biophys Res Commun; 1998 Nov; 252(1):134-8. PubMed ID: 9813158 [TBL] [Abstract][Full Text] [Related]
4. Dual roles of proteasome in the metabolism of presenilin 1. Honda T; Yasutake K; Nihonmatsu N; Mercken M; Takahashi H; Murayama O; Murayama M; Sato K; Omori A; Tsubuki S; Saido TC; Takashima A J Neurochem; 1999 Jan; 72(1):255-61. PubMed ID: 9886077 [TBL] [Abstract][Full Text] [Related]
5. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. Ancolio K; Marambaud P; Dauch P; Checler F J Neurochem; 1997 Dec; 69(6):2494-9. PubMed ID: 9375682 [TBL] [Abstract][Full Text] [Related]
6. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. Kim TW; Pettingell WH; Hallmark OG; Moir RD; Wasco W; Tanzi RE J Biol Chem; 1997 Apr; 272(17):11006-10. PubMed ID: 9110991 [TBL] [Abstract][Full Text] [Related]
7. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Leimer U; Lun K; Romig H; Walter J; Grünberg J; Brand M; Haass C Biochemistry; 1999 Oct; 38(41):13602-9. PubMed ID: 10521267 [TBL] [Abstract][Full Text] [Related]
8. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques. Steiner H; Revesz T; Neumann M; Romig H; Grim MG; Pesold B; Kretzschmar HA; Hardy J; Holton JL; Baumeister R; Houlden H; Haass C J Biol Chem; 2001 Mar; 276(10):7233-9. PubMed ID: 11084029 [TBL] [Abstract][Full Text] [Related]
9. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites. Sudoh S; Kawamura Y; Sato S; Wang R; Saido TC; Oyama F; Sakaki Y; Komano H; Yanagisawa K J Neurochem; 1998 Oct; 71(4):1535-43. PubMed ID: 9751187 [TBL] [Abstract][Full Text] [Related]
10. Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1. Marambaud P; Ancolio K; Alves da Costa C; Checler F Br J Pharmacol; 1999 Mar; 126(5):1186-90. PubMed ID: 10205007 [TBL] [Abstract][Full Text] [Related]
11. Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: different control of early and late events by the proteasome. Marambaud P; Lopez-Perez E; Wilk S; Checler F J Neurochem; 1997 Dec; 69(6):2500-5. PubMed ID: 9375683 [TBL] [Abstract][Full Text] [Related]
12. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. Steiner H; Capell A; Pesold B; Citron M; Kloetzel PM; Selkoe DJ; Romig H; Mendla K; Haass C J Biol Chem; 1998 Nov; 273(48):32322-31. PubMed ID: 9822712 [TBL] [Abstract][Full Text] [Related]
13. Role of the proteasome in Alzheimer's disease. Checler F; da Costa CA; Ancolio K; Chevallier N; Lopez-Perez E; Marambaud P Biochim Biophys Acta; 2000 Jul; 1502(1):133-8. PubMed ID: 10899438 [TBL] [Abstract][Full Text] [Related]
14. Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells. Refolo LM; Eckman C; Prada CM; Yager D; Sambamurti K; Mehta N; Hardy J; Younkin SG J Neurochem; 1999 Dec; 73(6):2383-8. PubMed ID: 10582597 [TBL] [Abstract][Full Text] [Related]
15. Specific increase in amyloid beta-protein 42 secretion ratio by calpain inhibition. Yamazaki T; Haass C; Saido TC; Omura S; Ihara Y Biochemistry; 1997 Jul; 36(27):8377-83. PubMed ID: 9204885 [TBL] [Abstract][Full Text] [Related]
16. Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin target. Hashimoto Y; Ito Y; Arakawa E; Kita Y; Terashita K; Niikura T; Nishimoto I J Neurochem; 2002 Feb; 80(3):426-37. PubMed ID: 11905990 [TBL] [Abstract][Full Text] [Related]
17. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. Crystal AS; Morais VA; Fortna RR; Carlin D; Pierson TC; Wilson CA; Lee VM; Doms RW Biochemistry; 2004 Mar; 43(12):3555-63. PubMed ID: 15035625 [TBL] [Abstract][Full Text] [Related]
18. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants. Saura CA; Tomita T; Soriano S; Takahashi M; Leem JY; Honda T; Koo EH; Iwatsubo T; Thinakaran G J Biol Chem; 2000 Jun; 275(22):17136-42. PubMed ID: 10748144 [TBL] [Abstract][Full Text] [Related]
19. Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway. Favit A; Grimaldi M; Alkon DL J Neurochem; 2000 Sep; 75(3):1258-63. PubMed ID: 10936209 [TBL] [Abstract][Full Text] [Related]
20. Effects of RNAi-mediated silencing of PEN-2, APH-1a, and nicastrin on wild-type vs FAD mutant forms of presenilin 1. Xie Z; Romano DM; Tanzi RE J Mol Neurosci; 2005; 25(1):67-77. PubMed ID: 15781968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]